BR0013781A - Pirazolo [4,3-d]pirimidinas - Google Patents

Pirazolo [4,3-d]pirimidinas

Info

Publication number
BR0013781A
BR0013781A BR0013781-2A BR0013781A BR0013781A BR 0013781 A BR0013781 A BR 0013781A BR 0013781 A BR0013781 A BR 0013781A BR 0013781 A BR0013781 A BR 0013781A
Authority
BR
Brazil
Prior art keywords
pyrimidines
pyrazolo
treatment
disorders
pirazole
Prior art date
Application number
BR0013781-2A
Other languages
English (en)
Inventor
Rochus Jonas
Hans-Michael Eggenweiler
Pierre Schelling
Maria Christadler
Norbert Beier
Original Assignee
Merc Patent Ges Mit Beschraenk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merc Patent Ges Mit Beschraenk filed Critical Merc Patent Ges Mit Beschraenk
Publication of BR0013781A publication Critical patent/BR0013781A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: "PIRAZOLO[4,3-d]PIRIMIDINAS". Pirazolo[4,3-d]pirimidinas da fórmula I e seus sais fisiologicamente aceitáveis. onde R^ 1^, R^ 2^, R^ 3^, R^ 4^ e X têm os significados indicados na reivindicação 1, exibem inibição de fosfodiesterase e podem ser empregados para o tratamento de distúrbios do sistema cardiovascular e para o tratamento e/ou terapia de distúrbios de potência.
BR0013781-2A 1999-09-06 2000-08-24 Pirazolo [4,3-d]pirimidinas BR0013781A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942474A DE19942474A1 (de) 1999-09-06 1999-09-06 Pyrazolo[4,3-d]pyrimidine
PCT/EP2000/008257 WO2001018004A2 (de) 1999-09-06 2000-08-24 PYRAZOLO[4,3-d]PYRIMIDINE

Publications (1)

Publication Number Publication Date
BR0013781A true BR0013781A (pt) 2002-05-14

Family

ID=7920966

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013781-2A BR0013781A (pt) 1999-09-06 2000-08-24 Pirazolo [4,3-d]pirimidinas

Country Status (23)

Country Link
US (1) US6777419B1 (pt)
EP (1) EP1210349B1 (pt)
JP (1) JP4975921B2 (pt)
KR (1) KR20020025253A (pt)
CN (1) CN1145627C (pt)
AR (1) AR025569A1 (pt)
AT (1) ATE231866T1 (pt)
AU (1) AU773878B2 (pt)
BR (1) BR0013781A (pt)
CA (1) CA2384037C (pt)
CZ (1) CZ294587B6 (pt)
DE (2) DE19942474A1 (pt)
DK (1) DK1210349T3 (pt)
ES (1) ES2189766T3 (pt)
HU (1) HUP0202624A3 (pt)
MX (1) MXPA02002383A (pt)
NO (1) NO20021083L (pt)
PL (1) PL353366A1 (pt)
PT (1) PT1210349E (pt)
RU (1) RU2249594C2 (pt)
SK (1) SK3132002A3 (pt)
WO (1) WO2001018004A2 (pt)
ZA (1) ZA200202653B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
CA2431077A1 (en) * 2000-12-19 2002-06-27 Merck Patent Gesellschaft Mit Beschraenkter Haftung Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
DE10103647A1 (de) 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
EA008596B1 (ru) 2003-04-29 2007-06-29 Пфайзер Инк. 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
DK1742950T3 (da) * 2004-04-07 2009-03-16 Pfizer Ltd Pyrazolo-[4,3-D]-pyrimidiner
CA2608018C (en) 2005-05-12 2010-07-13 Pfizer Inc. Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
NL2000291C2 (nl) 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
AU2012244550C1 (en) * 2011-04-21 2017-06-22 Origenis Gmbh Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
US10034861B2 (en) 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
LT3723807T (lt) 2017-12-14 2021-12-10 H. Lundbeck A/S Kombinuoti gydymai, apimantys 1h-pirazolo[4,3-b]piridinų vartojimą
AR113926A1 (es) 2017-12-14 2020-07-01 H Lundbeck As Derivados de 1h-pirazolo[4,3-b]piridinas
US10766893B2 (en) * 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
US11535611B2 (en) 2017-12-20 2022-12-27 H. Lundbeck A/S Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
DE10060388A1 (de) * 2000-12-05 2002-06-06 Merck Patent Gmbh Verwendung von Pyrazolo [4,3-d]pyrimidinen
DE10103647A1 (de) * 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates

Also Published As

Publication number Publication date
EP1210349A2 (de) 2002-06-05
KR20020025253A (ko) 2002-04-03
ZA200202653B (en) 2003-09-23
JP2003508534A (ja) 2003-03-04
DE19942474A1 (de) 2001-03-15
NO20021083D0 (no) 2002-03-05
JP4975921B2 (ja) 2012-07-11
CA2384037A1 (en) 2001-03-15
US6777419B1 (en) 2004-08-17
HUP0202624A2 (hu) 2002-12-28
WO2001018004A3 (de) 2001-08-09
EP1210349B1 (de) 2003-01-29
ATE231866T1 (de) 2003-02-15
DE50001191D1 (de) 2003-03-06
PT1210349E (pt) 2003-06-30
AR025569A1 (es) 2002-12-04
AU7279300A (en) 2001-04-10
RU2249594C2 (ru) 2005-04-10
CN1377357A (zh) 2002-10-30
CN1145627C (zh) 2004-04-14
DK1210349T3 (da) 2003-05-19
PL353366A1 (en) 2003-11-17
CZ294587B6 (cs) 2005-02-16
SK3132002A3 (en) 2002-07-02
MXPA02002383A (es) 2002-09-02
HUP0202624A3 (en) 2004-11-29
NO20021083L (no) 2002-03-05
CZ2002736A3 (cs) 2002-05-15
CA2384037C (en) 2009-10-13
AU773878B2 (en) 2004-06-10
WO2001018004A2 (de) 2001-03-15
ES2189766T3 (es) 2003-07-16

Similar Documents

Publication Publication Date Title
BR9712321A (pt) Aminotiofenocarboxamidas
WO2001019829A3 (en) Pyrazolopyrimidines as therapeutic agents
BR9815409A (pt) Tienopirimidinas
BR0011778A (pt) Tienopirimidinas
BG101289A (en) Pyrimido/5,4-d/pyrimidines, medicamentous forms containing them, their application and method for their preparation
BR9609617B1 (pt) derivados de 7h-pirrol[2,3-d]pirimidina, e composição farmacêutica.
MY119181A (en) Aryl pyrimidine derivatives
BR0210652A (pt) Pirrolopirimidinas como inibidores de proteìnas cinases
BR0313732A (pt) Compostos de pirimido tendo atividade antiproliferativa
BR9901491A (pt) 7-hetero-biciclo [2.2.1] - heptanos.
BR9906169A (pt) Derivados de pirrolo [1, 2-a] pirazina como ligandos sht 1a
TW200745123A (en) Pyrazolopyrimidines as protein kinase inhibitors
ATE377592T1 (de) Neurotropische substituierte pyrimidine
BR9814592A (pt) "compostos azopolicìclicos condensados com arila"
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
DK0888353T3 (da) N-7-Heterocyclyl-pyrrolo[2,3-d]pyrimidiner og deres anvendelse
BR0108715A (pt) Compostos de 3,4-diidro-1h-pirimido[4,5-d]-pirimidin-2-ona 1,5-dissubstituìdos e seu uso no tratamento de doenças mediadas pela cinase csbp/p38
BR9910032A (pt) Tienopirimidinas
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
CA2384037A1 (en) Pyrazolo[4,3-d]pyrimidines
TR200402342T4 (tr) 2-Pirindinil-6,7,8,9- Tetrahidropyrimido[1,2-A] Pirimidin-4-On ve 7-Pirindinil-1,3-Dihydoimidazo[1,2-A]Pirimidin-5(1H) on Türevleri
BR0213994A (pt) Derivados heterocìclicos de glicinamida e seus usos médicos
WO2002028860A3 (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
BR0213037A (pt) Derivados de pirimidina
BR0010560A (pt) 3-piridil-4-arilpirrois substituìdos e métodos terapêuticos e profiláticos relacionados

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.